Victory Capital Management Inc Kezar Life Sciences, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$7.99 - $10.75 $3.28 Million - $4.41 Million	-410,606 Reduced 14.82%	2,359,492 $20.3 Million
Q2 2022 Aug 01, 2022	BUY	$4.58 - $17.13 $4.66 Million - $17.4 Million	1,017,391 Added 58.05%	2,770,098 $22.9 Million
Q1 2022 May 04, 2022	BUY	$12.3 - $18.33 $17.2 Million - $25.6 Million	1,396,503 Added 392.05%	1,752,707 $29.1 Million
Q4 2021 Feb 07, 2022	SELL	$7.44 - $16.72 $1.58 Million - $3.54 Million	-212,020 Reduced 37.31%	356,204 $5.96 Million
Q3 2021 Nov 02, 2021	BUY	$4.85 - $9.73 $632,294 - $1.27 Million	130,370 Added 29.77%	568,224 $4.91 Million
Q2 2021 Aug 03, 2021	SELL	$4.93 - $6.46 $132,617 - $173,774	-26,900 Reduced 5.79%	437,854 $2.38 Million
Q1 2021 May 04, 2021	SELL	$5.24 - $6.99 $96,940 - $129,315	-18,500 Reduced 3.83%	464,754 $2.77 Million
Q4 2020 Feb 01, 2021	SELL	$4.77 - $6.58 $406,594 - $560,879	-85,240 Reduced 14.99%	483,254 $2.52 Million
Q3 2020 Nov 09, 2020	SELL	$4.36 - $5.5 $83,188 - $104,940	-19,080 Reduced 3.25%	568,494 $2.75 Million
Q2 2020 Aug 07, 2020	SELL	$3.6 - $7.75 $2.82 Million - $6.06 Million	-782,453 Reduced 57.11%	587,574 $3.04 Million
Q1 2020 May 04, 2020	BUY	$2.77 - $5.75 $2.42 Million - $5.03 Million	874,576 Added 176.52%	1,370,027 $5.97 Million
Q4 2019 Feb 06, 2020	SELL	$2.5 - $4.26 $1.95 Million - $3.32 Million	-779,612 Reduced 61.14%	495,451 $1.99 Million
Q4 2019 Feb 04, 2020	BUY	$2.5 - $4.26 $2.03 Million - $3.47 Million	813,492 Added 176.24%	1,275,063 $3.91 Million
Q3 2019 Nov 12, 2019	BUY	$3.0 - $7.58 $354 - $894	118 Added 0.03%	461,571 $1.51 Million
Q2 2019 Aug 15, 2019	BUY	$7.09 - $21.9 $1.68 Million - $5.19 Million	237,110 Added 105.69%	461,453 $3.56 Million
Q1 2019 May 03, 2019	SELL	$16.83 - $23.75 $39,550 - $55,812	-2,350 Reduced 1.04%	224,343 $3.98 Million
Q4 2018 Feb 05, 2019	SELL	$20.21 - $32.9 $4.01 Million - $6.53 Million	-198,497 Reduced 46.68%	226,693 $5.35 Million
Q3 2018 Nov 01, 2018	SELL	$15.5 - $21.41 $363,940 - $502,706	-23,480 Reduced 5.23%	425,190 $9.1 Million
Q2 2018 Aug 02, 2018	BUY	$17.15 - $17.79 $7.69 Million - $7.98 Million	448,670 New	448,670 $7.76 Million

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$46.7 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$32.8 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$23.7 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$17.9 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$16.4 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account